56 related articles for article (PubMed ID: 38473769)
1. Stereoselective Analysis of the Antiseizure Activity of Fenfluramine and Norfenfluramine in Mice: Is
Erenburg N; Perucca E; Bechard J; Dube C; Weishaupt N; Sherrington R; Bialer M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473769
[TBL] [Abstract][Full Text] [Related]
2. Enantioselective gas chromatographic assay with electron-capture detection for dl-fenfluramine and dl-norfenfluramine in plasma.
Srinivas NR; Hubbard JW; Cooper JK; Midha KK
J Chromatogr; 1988 Dec; 433():105-17. PubMed ID: 3235539
[TBL] [Abstract][Full Text] [Related]
3. Fenfluramine repurposing from weight loss to epilepsy: What we do and do not know.
Odi R; Invernizzi RW; Gallily T; Bialer M; Perucca E
Pharmacol Ther; 2021 Oct; 226():107866. PubMed ID: 33895186
[TBL] [Abstract][Full Text] [Related]
4. Enantioselective pharmacodynamic and pharmacokinetic analysis of two chiral CNS-active carbamate derivatives of valproic acid.
Shekh-Ahmad T; Mawasi H; McDonough JH; Finnell RH; Wlodarczyk BJ; Yavin E; Bialer M
Epilepsia; 2014 Dec; 55(12):1944-52. PubMed ID: 25442425
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of d- and l-norfenfluramine following their administration as individual enantiomers in rats.
Erenburg N; Hamed R; Shaul C; Barasch D; Perucca E; Bialer M
Epilepsia; 2024 Feb; 65(2):e14-e19. PubMed ID: 38041575
[TBL] [Abstract][Full Text] [Related]
6. Benfluorex metabolism complemented by electrochemistry-mass spectrometry.
Göldner V; Karst U
J Pharm Biomed Anal; 2023 Oct; 235():115626. PubMed ID: 37542830
[TBL] [Abstract][Full Text] [Related]
7. Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes.
Frampton JE
Drugs; 2023 Jul; 83(10):923-934. PubMed ID: 37316680
[TBL] [Abstract][Full Text] [Related]
8. Fenfluramine: a plethora of mechanisms?
Sourbron J; Lagae L
Front Pharmacol; 2023; 14():1192022. PubMed ID: 37251322
[TBL] [Abstract][Full Text] [Related]
9. Comparative activity of the enantiomers of fenfluramine and norfenfluramine in rodent seizure models, and relationship with their concentrations in plasma and brain.
Erenburg N; Hamed R; Shaul C; Perucca E; Bialer M
Epilepsia; 2023 Jun; 64(6):1673-1683. PubMed ID: 36995363
[TBL] [Abstract][Full Text] [Related]
10. The Quest for Secondary Pharmaceuticals: Drug Repurposing/Chiral-Switches Combination Strategy.
D'Acquarica I; Agranat I
ACS Pharmacol Transl Sci; 2023 Feb; 6(2):201-219. PubMed ID: 36798472
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation suggests fenfluramine and norfenfluramine are unlikely to act as perpetrators of drug interactions.
Martin P; Czerwiński M; Limaye PB; Ogilvie BW; Smith S; Boyd B
Pharmacol Res Perspect; 2022 Jun; 10(3):e00959. PubMed ID: 35599347
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
